Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 144–144 | Cite as

Ibrutinib

Development of resistance mutations leading to disease progression: 2 case reports
Case report
  • 14 Downloads

Reference

  1. Schier W, et al. Comparison of cellular and cell-free DNA for the detection and monitoring of BTK mutated CLL clones in patients with subsequent therapy after ibrutinib failure. HemaSphere 2 (Suppl. 1): 486 abstr. PS1082, Jun 2018. Available from: URL: http://doi.org/10.1097/HS9.0000000000000060 [abstract] -Germany

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations